Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A formulary for pediatric oncology in developing countries

Ronald D Barr¹, Alessandra Sala, John Wiernikowski

¹Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Pediatric Blood & Cancer

|March 12, 2005

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Trials·2026

Same author

The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literature.

Frontiers in pediatrics·2026

Same author

Antifungal Effect of the Proteolytic Fraction P1G10 Stabilized by Alginate-Chitosan Polyelectrolyte Complexation Against <i>Botrytis cinerea</i>.

Foods (Basel, Switzerland)·2026

Same author

Thrombopoietin Receptor Agonist (Avatrombopag) Preoperative Administration to Ameliorate Sepsis-Related Thrombocytopenia in Jehovah's Witness Patients Undergoing Redo Cardiac Surgery for Acute Endocarditis: A Case Report.

A&A practice·2026

Same author

Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report.

Frontiers in oncology·2026

Same author

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).

Leukemia & lymphoma·2026